Augmentation Strategies for Patients with Major Depressive Disorder with an Inadequate Response to Antidepressant Monotherapy
References
- 1. Mueller TI, Leon AC, Keller MB, et al. Recurrence after recovery from Major Depressive Disorder during 15 years of observational follow-up. Am J Psychiatry. 1999;156:1000-6.
- 2. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. Am J Psychiatry. 2006;163:28-40.
- 3. Bauer M, Bschor T, Pfennig A, et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. World J Biol Psychiatry. 2007;8:67-104.
- 4. Gabos Grecu I. Actualități în terapia depresiilor, Editura University Press, Tîrgu Mureș, 2007, pp. 116-129.
- 5. Moller HJ. Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment. World J Biol Psychiatry. 2008;9:102-14.
- 6. Mulder RT, Frampton CM, Luty SE, Joyce PR. Eighteen months of drug treatment for depression: Predicting relapse and recovery. J Affect Disord. 2009;114:263-70.
- 7. Judd LL, Schettler PJ, Akiskal HS. The prevalence, clinical relevance, and public health signifi cance of subthreshold depressions. Psychiatr Clin North Am. 2002;25:685-98.
- 8. McIntyre RS, O'Donovan C. The human cost of not achieving full remission in depression. Can J Psychiatry. 2004;49(Suppl 1):10S-16S.
- 9. Sobocki P, Jonsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health policy Econ. 2006;9:87-98.
- 10. Papakostas GI, Shelton RC, Smith J, Fava M. Augmentation of antidepressants with atypical antipsychotic medications for treatmentresistant major depressive disorder: a meta-analysis. J Clin Psychiatry. 2007;68:826-831.
- 11. McIntyre R, Katzman M. The role of atypical antipsychotics in bipolar depression and anxiety disorders. Bipolar Disord. 2003;5(Suppl 2):20-35.
- 12. Adson DE, Kushner MG, Eiben KM, Schulz SC. Preliminary experience with adjunctive quetiapine in patients receiving selective serotonin reuptake inhibitors. Depress Anxiety. 2004;19:121-126.
- 13. Yargic LI, Corapcioglu A, Kocabasoglu N, et al. A prospective randomized single-blind, multicenter trial comparing the effi cacy and safety of paroxetine with and without quetiapine therapy in depression associated with anxiety. Int J Psychiatry Clin Pract. 2004;8(4):205-211.
- 14. McIntyre A, Gendron A, McIntyre A. Quetiapine augmentation of SSRIs/ SNRIs in major depression with anxiety. 2006 in Poster presented at: American Psychiatric Association annual meeting, Toronto, Ontario.
- 15. Bauer M, El-Khalili N, Datto C, Szamosi J, Eriksson H. A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder. J Affect Disord. 2010;127(1-3):19-30.
DOI: https://doi.org/10.2478/amma-2014-0014 | Journal eISSN: 2668-7763 (formerly 2247-6113) | Journal ISSN: 2668-7755
Language: English
Page range: 61 - 66
Submitted on: Jun 11, 2013
Accepted on: Apr 9, 2014
Published on: Apr 25, 2014
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2014 Th Moica, I Gabos Grecu, Marieta Gabos Grecu, Melinda Ferencz, Elena Gabriela Buicu, Andreea Sălcudean, C Gabos Grecu, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.